Losartan 25mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Losartan potassium

Available from:

Kent Pharma (UK) Ltd

ATC code:

C09CA01

INN (International Name):

Losartan potassium

Dosage:

25mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 02050502; GTIN: 5015201007500

Patient Information leaflet

PATIENT INFORMATION
LEAFLET
LOSARTAN POTASSIUM 25MG, 50MG AND 100MG FILM-COATED
TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE, EVEN IF
YOU
HAVE JUST
HAD A REPEAT PRESCRIPTION. SOME OF THE INFORMATION I N YOUR PREVIOUS
LEAFLET MAY HAVE
CHANGED.
•
KEEP THIS LEAFLET. YOU MAY NEED TO READ IT
AGAIN.
•
IF YOU HAVE FURTHER QUESTIONS, PLEASE ASK YOUR DOCTOR OR YOUR
PHARMACIST.
•
THIS MEDICATION HAS BEEN PRESCRIBED FOR YOU. YOU SHOULD NOT PASS IT ON
TO
ANYONE ELSE. IT MAY HARM THEM, EVEN IF THEIR SYMPTOMS ARE THE SAME AS
YOURS.
•
IF ANY OF THE SIDE EFFECTS GET SERIOUS, OR IF YOU NOTICE ANY SIDE
EFFECTS THAT ARE
NOT
LISTED IN
THE LEAFLET, PLEASE TELL YOUR DOCTOR OR
PHARMACIST.
IN THIS
LEAFLET
1. What your medicine is and what it is used for
2. Before you take your medicine
3. How to take your medicine
4. Possible side effects
5. How to store your medicine
6. Further information
The name of your medicine is Losartan potassium 25mg, 50mg or 100mg
film-coated tablets. Your
medication is referred to as Losartan potassium tablets or Losartan
throughout this leaflet.
1. WHAT YOUR MEDICINE IS AND WHAT IT IS USED
FOR
Losartan belongs to a group of medicines known as angiotensin-II
receptor antagonists. Angiotensin
II is a chemical in your body, which tightens your blood vessels
making it harder for the blood to
pass through them and causes your blood pressure to increase.
Losartan blocks this effect, causing the blood vessels to relax and so
lowers your blood
pressure.
Your doctor has prescribed Losartan to:
•
TREAT HYPERTENSION
(high blood pressure) in adults and in children and adolescents 6-
18 years of age
•
PROTECT THE KIDNEY IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS WITH
LABORATORY
EVIDENCE OF
IMPAIRED RENAL FUNCTION AND PROTEINURIA ≥ 0.5MG PER DAY
(a condition in which urine
contains an abnormal amount of protein)
•
REDUCE THE RISK OF STROKE IN HYPERTENSION WITH LEFT VENTRICULAR
HYPERTROPHY
(thickening of the heart muscle)
•
TREAT CHRONIC HEART FAILURE
when treatment with

Summary of Product characteristics

OBJECT 1
LOSARTAN POTASSIUM 25MG FILM-COATED TABLETS
Summary of Product Characteristics Updated 27-Jan-2015 | Kent
Pharmaceuticals Ltd
1. Name of the medicinal product
Losartan potassium 25mg film- coated tablets
losartan potassium
2. Qualitative and quantitative composition
Each tablet contains 25mg of losartan potassium.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated tablet
Losartan potassium 25mg film- coated tablet is supplied as a white,
oblong, biconvex, non- scored film-
coated tablet.
4. Clinical particulars
4.1 Therapeutic indications
Losartan is indicated in:
- Treatment of essential hypertension in adults and in children and
adolescents 6-18 years of age.
- Treatment of renal disease in adult patients with hypertension and
type 2 diabetes mellitus with
proteinuria ≥ 0.5 g/day as part of an antihypertensive treatment
- Treatment of chronic heart failure (in patients ≥ 60 years), when
treatment with ACE inhibitors is not
considered suitable due to incompatibility, especially cough, or
contraindication. Patients with heart
failure who have stabilised with an ACE inhibitor should not be
switched to losartan. The patients should
have a left ventricular ejection fraction ≤ 40% and should be
stabilised under the treatment of chronic
heart failure.
- Reduction in the risk of stroke in hypertensive patients with left
ventricular hypertrophy documented by
ECG (See section 5.1)
4.2 Posology and method of administration
METHOD OF ADMINISTRATION
Losartan should be swallowed with a glass of water.
Losartan may be administered with or without food.
POSOLOGY
_Hypertension_
The usual starting and maintenance dose is 50 mg once daily for most
patients. The maximal
antihypertensive effect is attained 3-6 weeks after initiation of
therapy. Some patients may receive an
additional benefit by increasing the dose to 100 mg once daily (in the
morning).
Losartan may be administered with other antihypertensive agents,
especially with diuretics (e.g.
hydrochlorothiazide).
_Hypertensive ty